Ldbone-K2 Tablet contains a combination of Calcitriol, Calcium Citrate, Vitamin K2-7, Methylcobalamin, Zinc Oxide, Magnesium Oxide and L-Methyl Folate in tablet form.
It belongs to the Calcium Products category and is manufactured and marketed by HS Aldem Healthcare.
Composition
- Calcitriol: 0.25mcg
- Calcium Citrate: 500mg
- Vitamin K2-7: 45mcg
- Methylcobalamin: 1500mcg
- Zinc Oxide: 7.5mg
- Magnesium Oxide: 20mg
- L-Methyl Folate: 800mcg
Product Information
- Product Name: Ldbone-K2 Tablet
- Generic: Calcitriol 0.25mcg + Calcium Citrate 500mg + Vitamin K2-7 45mcg + Methylcobalamin 1500mcg + Zinc Oxide 7.5mg + Magnesium Oxide 20mg + L-Methyl Folate 800mcg
- Dosage Form: Tablet
- Manufacturer: HS Aldem Healthcare
- Marketer: HS Aldem Healthcare
- Category: Calcium Products
About the Ingredients
Calcitriol is the active form of vitamin D and plays an important role in calcium and phosphate metabolism.
Calcium Citrate is a source of calcium, an essential mineral that contributes to the maintenance of normal bones and teeth and supports normal muscle function.
Vitamin K2-7 is a form of vitamin K that contributes to normal blood clotting and the maintenance of normal bones.
Methylcobalamin is a form of vitamin B12 that contributes to normal red blood cell formation and normal nervous system function.
Zinc Oxide provides zinc, an essential mineral that contributes to normal immune function and protection of cells from oxidative stress.
Magnesium Oxide provides magnesium, an essential mineral that contributes to normal muscle and nervous system function and supports the maintenance of normal bones.
L-Methyl Folate is an active form of folate that contributes to normal blood formation and normal homocysteine metabolism.
Usage Information
Use Ldbone-K2 Tablet as directed by your doctor or healthcare professional. Follow the recommended dosage and instructions provided on the product packaging.
For complete product information, including storage instructions and expiry details, refer to the original packaging before use.
